BioVentrix, Inc. Announces German Reimbursement Designation
91 German Hospitals Now Eligible to Negotiate Full Coverage for Revivent Therapy MANSFIELD, MA, UNITED STATES, March 26, 2026 /EINPresswire.com/ -- BioVentrix, Inc. a private clinical-stage medical device company specializing in left ventricular …